West Pharmaceutical Services WST Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by West Pharmaceutical Services in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The official record: West Pharmaceutical Services’s 10-Q, filed July 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about West Pharmaceutical Services's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is West Pharmaceutical Services's accounts receivable?
- West Pharmaceutical Services (WST) reported accounts receivable of $712M in Q2 2026.
- How has West Pharmaceutical Services's accounts receivable changed year-over-year?
- West Pharmaceutical Services's accounts receivable increased by 22.3% year-over-year, from $582.4M to $712M.
- What is the long-term trend for West Pharmaceutical Services's accounts receivable?
- Over 5 years (2020 to 2025), West Pharmaceutical Services's accounts receivable has grown at a 8.3% compound annual growth rate (CAGR), from $385.3M to $574.4M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.